Every Little Helps: Shire Product Advances Fortify Takeda's Bid
Executive Summary
A positive opinion in the EU for Shire's Takhzyro and a favorable US advisory committee vote for prucalopride are incremental positives for Takeda's planned acquisition, on which shareholders are likely to vote in the coming weeks.